Expertise in
1
conditions

Chaim Lotan

Jerusalem, JM, IL 
Expertise in
1
conditions
Jerusalem, JM, IL 
OverviewLocationsClinical Research

Overview

Chaim Lotan practices in Jerusalem, Israel. Mr. Lotan is highly rated in 1 condition, according to our data. His top areas of expertise are Heart Failure, Ventricular Fibrillation, Mitral Valve Regurgitation, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 70 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Jerusalem, JM, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Non-Intervantional Study to Create a Patient Recordings and Clinical Database Using the Cordio System
A Non-Intervantional Study to Create a Patient Recordings and Clinical Database Using the Cordio System
Enrollment Status: Completed
Publish Date: March 09, 2021
Intervention Type: Device
A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions
A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions
Enrollment Status: Terminated
Publish Date: October 08, 2020
Intervention Type: Device
Study Phase: Phase 4
View 1 Less Clinical Trial

70 Total Publications

Short-term therapy with R568 ameliorated secondary hyperparathyroidism but does not prevent aortic valve calcification in uremic rats.
Short-term therapy with R568 ameliorated secondary hyperparathyroidism but does not prevent aortic valve calcification in uremic rats.
Journal: Frontiers in nephrology
Published: February 25, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lotan's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile